National Planning Corp Increases Holdings in Celgene Corporation (CELG)

Leslie Hanson
October 12, 2017

The Robertson Opportunity Capital Llc holds 45,000 shares with $2.05M value, down from 79,200 last quarter. The stock declined 0.57% or $0.09 reaching $15.76 per share. Another trade for 15,600 shares valued at $846,300 was sold by Shurts Wayne. CEVA, Inc. (NASDAQ:CEVA) has risen 66.60% since October 11, 2016 and is uptrending. It has outperformed by 28.72% the S&P500. Dillon & Associates Inc. increased its position in Celgene by 2.5% in the third quarter. Inc. now owns 773 shares of the biopharmaceutical company's stock valued at $100,000 after acquiring an additional 43 shares during the period. Celgene Corp now has $108.96B valuation.

In other Celgene Corporation news, insider Terrie Curran sold 1,727 shares of the company's stock in a transaction dated Monday, September 25th. Ltd. now owns 1,180 shares of the biopharmaceutical company's stock worth $147,000 after purchasing an additional 380 shares in the last quarter. Tompkins Finance Corporation holds 0.57% of its portfolio in Celgene Corporation (NASDAQ:CELG) for 17,324 shares. It has outperformed by 0.30% the S&P500. It also upped Alibaba Group Hldg Ltd (NYSE:BABA) stake by 19,054 shares and now owns 829,654 shares.

The stock of Pieris Pharmaceuticals Inc (NASDAQ:PIRS) is a huge mover today!

Investors sentiment increased to 1.14 in Q2 2017. The biopharmaceutical company reported $1.82 EPS for the quarter, topping analysts' consensus estimates of $1.61 by $0.21. Allen Invest Mgmt stated it has 7,859 shares or 0.05% of all its holdings. After $0.18 actual earnings per share reported by CEVA, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth. The shares were sold at an average price of $141.56, for a total transaction of $1,309,430.00. Massmutual Tru Company Fsb Adv has invested 0% in Celgene Corporation (NASDAQ:CELG). 3,559 are held by Gideon Capital Advsr. Huntington National Bank now owns 20,415 shares of the biopharmaceutical company's stock worth $2,133,000 after buying an additional 13,063 shares during the last quarter.

Checking out a public company's Earnings per Share (EPS) is a smart way of assessing its profitability. Gsa Llp invested in 13,451 shares or 0.01% of the stock. Whale Rock Capital Mngmt Ltd Liability Corporation, a Massachusetts-based fund reported 468,040 shares. Bollard Group Limited Liability Company invested 0.78% of its portfolio in Enbridge Energy Management, L.L.C. (NYSE:EEQ). Texas Yale Cap holds 0.12% of its portfolio in Enbridge Energy Management, L.L.C. (NYSE:EEQ) for 89,537 shares. Tiedemann Wealth Mngmt Ltd Liability Corporation invested 0.02% of its portfolio in Enbridge Energy Management, L.L.C. (NYSE:EEQ).

Since May 8, 2017, it had 0 insider buys, and 9 sales for $6.77 million activity. It improved, as 16 investors sold CEVA shares while 47 reduced holdings. Its up 4.76% from 8.56M shares previously. BIENAIME JEAN JACQUES had bought 500 shares worth $57,500 on Monday, May 15. Shares for $1.20 million were sold by MCMANAMON PETER. Celgene Corporation now has an average rating of Buy and an average price target of $150.60. Therefore 83% are positive. Enbridge Energy Management LLC had 10 analyst reports since September 11, 2015 according to SRatingsIntel. Zacks upgraded the stock to "Hold" rating in Monday, August 10 report. Finally, Bank of America Corporation reiterated a "buy" rating on shares of Celgene Corporation in a research note on Wednesday, September 13th. The company was maintained on Wednesday, October 4 by Jefferies.

Goldman Sachs Group Inc restated their sell rating on shares of Celgene Co. Stifel Nicolaus maintained the stock with "Buy" rating in Friday, July 28 report. The stock of Celgene Corporation (NASDAQ:CELG) earned "Buy" rating by Oppenheimer on Wednesday, June 14. The company was maintained on Wednesday, July 5 by Oppenheimer. As per Friday, May 5, the company rating was downgraded by Argus Research. The stock of PrairieSky Royalty Ltd (TSE:PSK) has "Sector Perform" rating given on Wednesday, October 26 by RBC Capital Markets. The firm earned "Hold" rating on Sunday, August 20 by RBC Capital Markets.

Healthcor Management Lp decreased Aetna Inc New (NYSE:AET) stake by 675,000 shares to 900,000 valued at $136.65M in 2017Q2. Mckesson Corp (NYSE:MCK) was raised too.

In the most recent financial results released by Celgene Corporation, for the quarter ending on 2017-06-30, the company posted EPS of 1.82. Its up 0.21, from 1.13 in 2017Q1. It increased, as 60 investors sold Celgene Corporation shares while 390 reduced holdings.

Institutional investors and hedge funds have recently made changes to their positions in the company. 602.51 million shares or 1.81% more from 591.78 million shares in 2017Q1 were reported. Ing Groep Nv holds 7,654 shares. The Company also markets ISTODAX, which is an epigenetic modifier. Also, Celgene Corporation (CELG) needs to expand a 33.97% increase it experienced over the past twelve months. Welch Capital Prns Ltd Liability Corporation New York has invested 1.67% of its portfolio in Celgene Corporation (NASDAQ:CELG). Argent has invested 0.64% in Celgene Corporation (NASDAQ:CELG). 2,800 were accumulated by Lafleur & Godfrey Lc. Stephens Ar owns 55,201 shares for 0.25% of their portfolio. 19,749 are held by Next Century Growth Lc.

Since June 15, 2017, it had 0 buys, and 3 insider sales for $2.36 million activity. Main Street Research Ltd holds 0.3% in Celgene Corporation (NASDAQ:CELG) or 14,028 shares. Friedman Michael A sold $625,000 worth of stock. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and twenty-two have given a buy rating to the stock. Therefore 85% are positive. SunTrust Banks, Inc. set a $150.00 target price on shares of Celgene Corporation and gave the company a buy rating in a research note on Thursday, July 6th. JMP Securities maintained it with "Market Outperform" rating and $152 target in Wednesday, March 9 report. The firm has "Buy" rating given on Thursday, September 29 by Citigroup. BMO Capital Markets maintained Celgene Corporation (NASDAQ:CELG) on Friday, July 28 with "Outperform" rating. The firm has "Outperform" rating by Scotia Capital given on Friday, November 11.

Other reports by Iphone Fresh

Discuss This Article